Patients in UK get early access to GSK’s Jemperli
It concerns the treatment being combined with platinum-containing chemotherapy
Read More
Tag: Jemperli
Accelerated FDA approval for GSK’s Jemperli
Indicated for the treatment of of dMMR recurrent or advanced solid tumours
Read More
GSK’s PD-1 inhibitor Jemperli approved in the UK
Conditional marketing authorisation granted for the treatment of recurrent or advanced endometrial cancer
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
